Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Amortizatization of Intangibles (2020 - 2025)

Black Diamond Therapeutics (BDTX) has disclosed Amortizatization of Intangibles for 2 consecutive years, with $4.0 million as the latest value for Q4 2021.

  • For the quarter ending Q4 2021, Amortizatization of Intangibles rose 444.22% year-over-year to $4.0 million, compared with a TTM value of $2.2 million through Dec 2021, up 26.72%, and an annual FY2024 reading of $3.8 million, up 222.15% over the prior year.
  • Amortizatization of Intangibles was $4.0 million for Q4 2021 at Black Diamond Therapeutics, up from -$488000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $4.0 million in Q4 2021 and bottomed at -$720000.0 in Q1 2021.